Evidence map›Paper›PMID 40974405›Full record

ArticleJournal of neurology2025

Clinical phenotype associated with A118V mutation of PRPN gene.

Thomas Giannelli, Anna Ladogana, Dorina Tiple, Luana Vaianella, Anna Poleggi, Giorgia Ruta, Dalila Totaro, Giancarlo Logroscino, Damiano Paolicelli, Alessandro Introna

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas GiannelliDepartment of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari "Aldo Moro", Bari, Italy. tp.giannelli@gmail.com.ORCID http://orcid.org/0009-0003-4323-9142
Anna LadoganaDepartment of Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-7504-6906
Dorina TipleDepartment of Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0001-7155-4957
Luana VaianellaDepartment of Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-6642-8304
Anna PoleggiDepartment of Neuroscience, Istituto Superiore Di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0001-7094-7767
Giorgia RutaDepartment of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.
Dalila TotaroDepartment of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.
Giancarlo Logroscino *Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.ORCID http://orcid.org/0000-0003-0423-3242
Damiano Paolicelli *Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.ORCID http://orcid.org/0000-0002-8645-1763
Alessandro Introna *Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari "Aldo Moro", Bari, Italy.ORCID http://orcid.org/0000-0002-3141-6442

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCreutzfeldt-Jakob disease (CJD) is the most common human prion disease, with genetic forms linked to PRNP gene mutations accounting for 10-15% of cases. We present a case of probable genetic prion disease associated with a novel PRNP mutation. CASE PRESENTATION: A previously healthy 60-year-old woman developed gait ataxia and micrographia. Six months later, she experienced severe anxiety, emotional lability, and visual hallucinations. Brain magnetic resonance imaging (MRI) showed cortical ribboning in the frontal-insular regions. Her condition progressed to walking dependence and cerebellar dysarthria. She died 15 months after symptom onset. CSF analysis revealed elevated total-Tau (1933 pg/mL; reference < 450 pg/mL). RT-QuIC assay using full-length recombinant PrP was negative. Genetic testing revealed a Met/Val polymorphism at codon 129 and a novel heterozygous A118V mutation in the PRNP gene. A second RT-QuIC using truncated PrP confirmed abnormal prion seeds, supporting a probable diagnosis of prion disease.

conclusionsThe compound heterozygous A118V and M129V PRNP variant had not previously been associated with prion disease. Family history was unobtainable, as relatives declined testing. The patient's presentation-cerebellar and psychiatric symptoms-resembled Gerstmann-Sträussler-Scheinker syndrome, though a definitive diagnosis was not possible without neuropathology. MRI and RT-QuIC findings supported prion disease. The positive result with truncated PrP highlights its diagnostic value, offering improved sensitivity. This case underscores the phenotypic diversity of PRNP mutations and the importance of molecular testing, especially when family history or neuropathology is unavailable. PRNP gene analysis should be considered in patients with rapidly progressive motor and cognitive symptoms suggestive of prion disease.

Indexed as

Creutzfeldt-Jakob SyndromePrion ProteinsBrainFatal OutcomeFemaleHumansMiddle AgedMutationPrion ProteinsPRNP protein, humanCJDCreutzfeldt–Jakob diseaseGeneticGSSNovel mutationPrion diseaseSecond-generation RT-QuIC

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.